Heart Valve Society of America, New York
April 12 - 14, 2007
Wednesday, April 11, 20076:00 – 8:00 P.M. Registration
Thursday, April 12, 2007
7:00 – 7:45 Registration and Continental Breakfast 7:45 – 7:55 Introduction and Symposium Goals
O. Wayne Isom, M.D., Jeffrey S. Borer, M.D. 7:55 – 8:00 Welcome from the American College of Cardiology
Paul Kligfield, M.D.
President, American College of Cardiology, New York State Chapter
8:00 – 8:05 Welcome from the Heart Valve Society of America
Jeffrey S. Borer, M.D. 8:05 – 10:30 OVERVIEW
Chairman: O. Wayne Isom, M.D.
8:05 – 8:25 THE HOWARD GILMAN FOUNDATION LECTURE
Percutaneous Valve Replacement and Repair: Where Do We Stand —The Balance Between Investigator Enthusiasm and Regulatory Standards
Bram Zuckerman, M.D.
8:25 – 8:40 The epidemiology of valvular heart diseases: New data, new problems
Phyllis Supino, Ed.D.
8:40 – 8:55 Mechanisms of myocardial dysfunction in VHD: Impact on therapeutic decisions
Jeffrey S. Borer, M.D.
8:55 – 9:10 Proper pre-operative preparation of the patient with valvular heart disease to minimize anesthetic complications
Stephen Thomas, M.D. 9:10 – 9:25 Systolic and diastolic mechanics of valve disease: Implications for selection of therapy
Blase Carabello, M.D. 9:25 – 9:40 Age: Is it a selection factor for valve surgery?
Karl Krieger, M.D. 9:40 – 9;55 Alternative medicine strategies: What do they offer for the patient with VHD?
Mehmet Oz, M.D. 9:55 -10:25 Panel Discussion/Q & A
Chairman: O.Wayne Isom, M.D.; Panelists: Drs. Borer, Supino, Carabello, Oz, Thomas, Krieger, Zuckerman 10:25 – 10:55 Coffee Break/Posters 10:55 – 12:25 AORTIC VALVE DISEASE I
Chairman: Lawrence Cohn, M.D. 10:55 – 11:15 Anti-coagulation for prosthetic valves and AF: How do you do it and how do you interrupt it?
Valentin Fuster, M.D., Ph.D.
11:15 – 11:30 Operation for AS primarily in the asymptomatic patient: The time has come
Jamil Tajik, M.D.
11:30 – 11:45 We should provide statin prophylaxis for patients with AS: A critical appraisal of clinical data and their scientific basis
Nalini Rajamannan, M.D. 11:45 – 12:00 Coronary disease and AS: When can you ignore the CAD? When should you perform a “hybrid” procedure?
Richard J. Shemin, M.D. 12:00 – 12:30 Panel Discussion/Q & A
Chairman: Lawrence Cohn, M.D. Panelists: Drs. Tajik, Shermin, Rajamannan, Fuster, Pai 12:30 – 2:00 Lunch
Poster presentations of refereed abstracts
2:00 – 3:00 CASE PRESENTATIONS AND DISCUSSION
Chairman: Maurice E. Sarano, M.D 1. Mitral valve patient prosthesis mismatch.
2. Robotic valve surgery
3. Subvalvular aortic stenosis
4. Aortic stenosis in young man — The Ross Procedure
5. Infective endocarditis Panel: Drs. Chen, Stelzer, McCarthy, Cohn, Oz, Pibarot, Tajik, Shermin, Herrold, Pai
3:00 – 4:30 AORTIC VALVE DISEASE II
Chairman: Mark Starling, M.D.
3:00 – 3:15 Drug prophylaxis for asymptomatic AR: Is it indicated?
Robert O Bonow, M.D 3:15 – 3:30 Indication for operation AR: the symptomatic and asymptomatic patient
Jeffrey S. Borer, M.D. 3:30 – 3:45 Patient prosthetic mismatch: Implications for outcome in aortic valve disease
Philippe Pibarot, D.V.M., Ph.D. 3:45 – 4:00 Aortic valve replacement: valve selection to match patient to prosthesis
Mark Gilinov, M.D. 4:00 – 4:15 Apical-aortic conduit for aortic stenosis when ascending aortic —Calcification is severe
John Brown, M.D. 4:15 – 4:45 Coffee break/Posters 4:45 – 6:15 THE AORTIC ROOT AND ASSOCIATED VALVE DISEASE
Chairman: Richard J. Shemin, M.D. 4:45 – 5:15 Debate: When the aortic root is aneurismal and the aortic valve is incompetent, the valve should be repaired
Pro: Hartzell Schaff
Con: Leonard Girardi 5:15 – 5:30 Bicuspid aortic valve: exercise restriction, medication, root replacement — when is each appropriate?
John Elefteriadis, M.D. 5:30 – 5:45 Valve-sparing aortic root replacement
Alan Hilgenberg, M.D. 5:45 – 6:15 Panel Discussion/Q & A
Chairman: To be determined
Panelists: Drs Bonow, Schaff, Brown, Pibarot, Girardi, Elefteriadis, Hilgenberg, Brown, Gilinov, Pibarot, Starling, Borer
.
FRIDAY, APRIL 13, 2007 7:00 – 7:45 A.M. Continental breakfast
7:45 – 10:30 A.M. SPLIT SESSION:
1. Echocardiography – current standards and techniques – Judy Hung, M.D., Chairperson; Drs. Tajik, Sarano, Goldman, St John Sutton
2. Surgical techniques and decisions Chairman O. Wayne Isom, M.D. ; Intraoperative echos: TBD
a. Mitral valve repair – non-ischemic
b. Minimally invasive aortic valve replacement
c. Mitral valve repair
d. Aortic root replacement with aortic valve repair Akins, Adams, Elefteriadis, Krieger, Sahn, Schaff, McCarthy, Galloway, Girardi, Cohn. Herrold 10:30 – 11:00 Coffee break/Posters 11:00 – 12:30 MITRAL REGURGITATION I
Chairman: A. Jamil Tajik, M.D. 11:00 – 11:15 Echocardiographic quantitation of MR
A. Jamil Tajik, M.D. 11:15 – 11:30 Indications for mitral valve surgery: impact of symptoms, ventricular function and atrial rhythm
Maurice E. Sarano, M.D. 11:30 – 11:45 Ventricular arrhythmias and MR: implications for timing of surgery and post-op care
Clare Hochreiter, M.D. 11:45 – 12:00 Prophylactic drug treatment for MR: beta blockade? vasodilatation? nothing?
Robert O Bonow, M.D. 12:00 – 12:30 Panel Discussion/Q & A
Chairman: A. Jamil Tajik, M.D.; Panelists: Drs. Bonow, Goldman, Carabello, Hochreiter, Sarano, Starling 12:30 – 2:00 Lunch
SPLIT SESSION
A. Allied Health Professionals in VHD care
Chairpersons: Beth Eichhorn, RN; Jerene Bitondo, PA 1. Home monitoring of INR: is the US behind the curve?
Jerene Bitondo, PA
2. Bridging anticoagulation for intercurrent procedures: is there a best approach?
TBD
3. Interpretation of hemodynamic data from catheterization
Warren Laskey, M.D.
4. Patient Education – materials and methods
Beth Eichhorn, RN B. Poster presentations of refereed abstracts
2:15 – 4:00 MITRAL REGURGITATION II
Chairman: David Adams, M.D.
2:15 – 2:45 Debate:
In patients with VHD, pulmonary vein isolation for AF should be reserved only for surgery
Pro: Charles Mack, M.D.
Con: Larry Chinitz, M.D. 2:45 – 3:00 Structural basis of ischemic MR – implications for therapy
Robert Levine, M.D. 3:00 – 3:15 Ischemic MR: when to operate
Maurice E. Sarano 3;15 – 3:30 Mitral valve replacement for MR: when is it still indicated?
Cary W. Akins, M.D. 3:30 – 3:45 Coronary Disease and MR – when do you fix both? How do you fix both?
David Adams, M.D. 3:45 – 4:15 Panel Discussion/Q & A
Chairman: David Adams, M.D.; Panelists: Drs. Akins, Chinitz, Mack, Levine, Sarano, Starling
4:15 – 4:45 Coffee break/Posters
4:45 – 6:30 MITRAL REGURGITATION III AND TRICUSPID VALVE DISEASE
Chairman: Cary Akins, M.D. 4:45 – 5:15 Mitral regurgitation in cardiomyopathy should be managed medically
Pro: Blase Carabello
Con: Steven F. Bolling, M.D. 5:15 – 5:30 Secondary MR is best treated with biventricular pacing: a supportable strategy?
Martin G. St. John Sutton, M.D. 5:30 – 5:45 Infective endocarditis: scope of the problem and medical/surgical management strategy
Patrick J. O’Gara 5:45 - 6:00 When to correct tricuspid regurgitation
Patrick McCarthy 6:00 – 6:30 Panel Discussion/Q & A
Chairman: Cary Akins, M.D.; Panelists: Drs. Carabello, Bolling, St. John Sutton, O’Gara, McCarthy, Starling SATURDAY, APRIL 14, 2007 7:00 – 8:00 A.M. Continental breakfast 8:00 – 9:20 PERCUTANEOUS REPAIRS
Chairman: Jagat Narula, M.D. 8:00 – 8:20 Percutaneous mitral valve repair: current techniques and results
Ted Feldman 8:20 – 8:35 Re-operation for valve disease: impact of technical concerns on indications for re-operation and selection of procedures
Craig Smith, M.D. 8:35 – 8:55 Mitral stenosis: indications for mechanical therapy and comparative results of balloon valvulosplasty versus surgery
Igor F. Palacios, M.D. 8:55 – 9:10 Percutaneous aortic valve repair: techniques and current data
Allan Schwartz, M.D.
9:10 – 9:25 Percutaneous correction of asymmetric septal hypertrophy
Michael Fifer, M.D. 9:25 – 9:40 Clinical evaluation: Is there any place for symptom determination and physical examination in the world of echo evaluation and percutaneous therapy?
Sabhudin Rahimtoola, M.D 9:40 – 10:05 Coffee break/Posters 10;05 -- 11:45 CASE PRESENTATIONS AND DISCUSSION
Chairman: Warren Laskey, M.D. 1. Infiltrative cardiomyopathy with MR
2. Long vegetation in IE
3. Radiation-induced valve disease
4. Rapid progression of LV size in AR
5. RV changes in MR
6. AS and AF
7. Tricuspid Flail Leaflet
Expert Panel: Drs. Sarano, Tajik, Fifer, Feldman, Smith, Narula, Palacios, Schwartz, Herrold
11:45 – 11:55 Closing remarks 11:55– 12:00 Participants complete and submit course evaluation and CME form
|